Science Explorer Interactive view Map
Hospital / health system · Atlanta · ??

Winship Cancer Institute

In research, Winship Cancer Institute stands highest in Medicine (#5,724 of 10,443 worldwide) and Health Sciences (#7,368 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 17.0× its share of world research.

winshipcancer.emory.eduROR OpenAlex
World rank, 2022–2025
#12,477
of 28,054 · #11,114 all time
Rank in ??
#229
of 692
Research works
656
▲ 8% vs 2013–17
Citations
23k
34.9 per fractional work
Top-10% rate
14.9%
record average 16.5%
Open access
38%
world 28%

What is Winship Cancer Institute known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #5,724 of 10,443 13.1%73 #4683
Health SciencesDomain #7,368 of 11,982 13.5%76 #6425

Each strip is that field’s whole ranked pool, with the notch where Winship Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Winship Cancer Institute specialise in?

Where its research is concentrated relative to its size: Oncology takes 17.0× the share of its output that it takes of world research.

  1. OncologySubfield · 20.4 works17×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.02× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.88× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 4.38× its world share, 5 worksImmunology and Micro…Neuroscience: 0.87× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.15× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.20× its world share, 0 worksChemistryComputer Science: 0.10× its world share, 1 worksComputer ScienceEngineering: 0.06× its world share, 1 worksEngineeringMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMathematics: 0.16× its world share, 0 worksMathematicsPhysics and Astronomy: 0.48× its world share, 1 worksPhysics and AstronomyHealth Professions: 0.98× its world share, 3 worksHealth ProfessionsMedicine: 3.57× its world share, 73 worksMedicineNursing: 0.32× its world share, 0 worksNursingArts and Humanities: 0.02× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.03× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.06× its world share, 2 worksEconomics, Econometr…Psychology: 0.11× its world share, 0 worksPsychologySocial Sciences: 0.07× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.4×. Every wedge is a field page.

Which keywords describe research at Winship Cancer Institute?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Clinical Trials, Tumor Microenvironment, Targeted Therapy, Prognostic Factors, Radiotherapy and Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy14▲ 18×16 topics
  2. Chemotherapy12▲ 16×19 topics
  3. Clinical Trials9▲ 12×8 topics
  4. Tumor Microenvironment9▲ 18×8 topics
  5. Targeted Therapy8▲ 34×4 topics
  6. Prognostic Factors7▲ 15×14 topics
  7. Cancer7▲ 4.9×26 topics
  8. Radiotherapy6▲ 15×12 topics
  9. Inflammation6▲ 2.5×27 topics
  10. Staging System6▲ 85×2 topics
  11. Lymphoma5▲ 31×4 topics
  12. Minimal Residual Disease5▲ 72×2 topics
  13. Proteasome Inhibitors5▲ 69×2 topics
  14. Cancer Immunotherapy5▲ 31×3 topics
  15. Diagnosis Criteria5▲ 133×1 topic
  16. International Myeloma Working Group5▲ 133×1 topic
  17. Biomarkers5▲ 6.5×7 topics
  18. Genomic Profiling5▲ 42×2 topics
  19. Metastasis4▲ 12×8 topics
  20. Neoadjuvant Therapy4▲ 17×5 topics
  21. Breast Cancer4▲ 15×9 topics
  22. Cancer Therapy4▲ 6.5×11 topics
  23. Immune Checkpoint Blockade4▲ 33×1 topic
  24. PD-1 and PD-L14▲ 33×1 topic
  25. Tumor Regression4▲ 33×2 topics
  26. Leukemia4▲ 40×2 topics
  27. Precision Medicine4▲ 7.2×6 topics
  28. ALK Inhibitors3▲ 49×1 topic
  29. EGFR Mutations3▲ 49×1 topic
  30. Genetic Mutations3▲ 7.2×9 topics
  31. PET Imaging3▲ 18×4 topics
  32. Survival Analysis3▲ 11×6 topics
  33. Treatment Guidelines3▲ 14×3 topics
  34. Clinical Practice Guidelines3▲ 5.6×8 topics
  35. CAR T Cells3▲ 39×1 topic
  36. Chimeric Antigen Receptor3▲ 39×1 topic
  37. Metastatic Breast Cancer3▲ 49×2 topics
  38. Prognosis3▲ 8.1×5 topics
  39. Tumor Markers3▲ 32×2 topics
  40. Genomic Profiles2▲ 56×1 topic

Which research topics does Winship Cancer Institute publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and CAR-T cell therapy research.

Multiple Myeloma Research and Treatments: 5 fractional worksCancer Immunotherapy and Biomarkers: 4 fractional worksLung Cancer Treatments a…3Lung Cancer Treatments and Mutations: 3 fractional worksCAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksLung Cancer Research Studies: 2 fractional worksAdvanced Breast Cancer Therapies: 2 fractional worksPancreatic and Hepatic O…2Pancreatic and Hepatic Oncology Research: 2 fractional worksRadiomics and Machine Learning in Medical Imaging: 2 fractional worksHead and Neck Cancer Studies: 2 fractional worksLymphoma Diagnosis and Treatment: 2 fractional works
HematologyOncologyPulmonary and Respiratory MedicineRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Multiple Myeloma Research and Treatments Hematology 5 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 4 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
  4. 4 CAR-T cell therapy research Oncology 3 works
  5. 5 Lung Cancer Research Studies Oncology 2 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  7. 7 Pancreatic and Hepatic Oncology Research Oncology 2 works
  8. 8 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works
  9. 9 Head and Neck Cancer Studies Otorhinolaryngology 2 works
  10. 10 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.8%not open62.2%

World: 28% of research is openly available.

with international co-authors17.8%domestic only82.2%

World: 19% is written across borders.

How has Winship Cancer Institute's research output changed?

Output in 2018–2022 was 8% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Atlanta

All research institutions in Atlanta

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.